Literature DB >> 25883218

Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.

Yonggang Ma1, Ying Ann Chiao2, Ryan Clark1, Elizabeth R Flynn1, Andriy Yabluchanskiy1, Omid Ghasemi3, Fouad Zouein1, Merry L Lindsey4, Yu-Fang Jin5.   

Abstract

AIMS: Cardiac ageing involves the progressive development of cardiac fibrosis and diastolic dysfunction coordinated by MMP-9. Here, we report a cardiac ageing signature that encompasses macrophage pro-inflammatory signalling in the left ventricle (LV) and distinguishes biological from chronological ageing. METHODS AND
RESULTS: Young (6-9 months), middle-aged (12-15 months), old (18-24 months), and senescent (26-34 months) mice of both C57BL/6J wild type (WT) and MMP-9 null were evaluated. Using an identified inflammatory pattern, we were able to define individual mice based on their biological, rather than chronological, age. Bcl6, Ccl24, and Il4 were the strongest inflammatory markers of the cardiac ageing signature. The decline in early-to-late LV filling ratio was most strongly predicted by Bcl6, Il1r1, Ccl24, Crp, and Cxcl13 patterns, whereas LV wall thickness was most predicted by Abcf1, Tollip, Scye1, and Mif patterns. With age, there was a linear increase in cardiac M1 macrophages and a decrease in cardiac M2 macrophages in WT mice; of which, both were prevented by MMP-9 deletion. In vitro, MMP-9 directly activated young macrophage polarization to an M1/M2 mid-transition state.
CONCLUSION: Our results define the cardiac ageing inflammatory signature and assign MMP-9 roles in mediating the inflammaging profile by indirectly and directly modifying macrophage polarization. Our results explain early mechanisms that stimulate ageing-induced cardiac fibrosis and diastolic dysfunction. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac ageing; Inflammation; MMP-9; Macrophage polarization; Proteomics

Mesh:

Substances:

Year:  2015        PMID: 25883218      PMCID: PMC4498140          DOI: 10.1093/cvr/cvv128

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

1.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

2.  Macrophages in the infarct: fiery friends or friendly fire?

Authors:  Matthias Nahrendorf
Journal:  J Mol Cell Cardiol       Date:  2012-09-10       Impact factor: 5.000

3.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats.

Authors:  Lei Han; Minggao Li; Yongxue Liu; Chunguang Han; Ping Ye
Journal:  Pharmacology       Date:  2012-02-14       Impact factor: 2.547

5.  Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging.

Authors:  Yonggang Ma; Ying Ann Chiao; Jianhua Zhang; Anne M Manicone; Yu-Fang Jin; Merry L Lindsey
Journal:  Microsc Microanal       Date:  2011-12-08       Impact factor: 4.127

Review 6.  Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities.

Authors:  Debapriya Dutta; Riccardo Calvani; Roberto Bernabei; Christiaan Leeuwenburgh; Emanuele Marzetti
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

7.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

8.  Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.

Authors:  Rogelio Zamilpa; Jessica Ibarra; Lisandra E de Castro Brás; Trevi A Ramirez; Nguyen Nguyen; Ganesh V Halade; Jianhua Zhang; Qiuxia Dai; Tariq Dayah; Ying Ann Chiao; Wesley Lowell; Seema S Ahuja; Jeanine D'Armiento; Yu-Fang Jin; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2012-08-03       Impact factor: 5.000

9.  Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile.

Authors:  Evi M Mercken; Seth D Crosby; Dudley W Lamming; Lellean JeBailey; Susan Krzysik-Walker; Dennis T Villareal; Miriam Capri; Claudio Franceschi; Yongqing Zhang; Kevin Becker; David M Sabatini; Rafael de Cabo; Luigi Fontana
Journal:  Aging Cell       Date:  2013-06-05       Impact factor: 9.304

Review 10.  MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.

Authors:  Ying Xia; Nikolaos G Frangogiannis
Journal:  Inflamm Allergy Drug Targets       Date:  2007-06
View more
  47 in total

Review 1.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

2.  Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition.

Authors:  Merry L Lindsey; Andriy Yabluchanskiy; Yonggang Ma
Journal:  Cardiology       Date:  2015-08-01       Impact factor: 1.869

3.  Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.

Authors:  JoAnn Trial; Celia Pena Heredia; George E Taffet; Mark L Entman; Katarzyna A Cieslik
Journal:  Basic Res Cardiol       Date:  2017-05-06       Impact factor: 17.165

4.  Current themes in myocardial and coronary vascular aging.

Authors:  Amanda J LeBlanc; Natia Q Kelm; Monika George
Journal:  Curr Opin Physiol       Date:  2017-12-13

Review 5.  Proteomic analysis of the cardiac extracellular matrix: clinical research applications.

Authors:  Merry L Lindsey; Mira Jung; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Expert Rev Proteomics       Date:  2018-01-09       Impact factor: 3.940

6.  Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Authors:  Hiroe Toba; Presley L Cannon; Andriy Yabluchanskiy; Rugmani Padmanabhan Iyer; Jeanine D'Armiento; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

Review 7.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

8.  IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.

Authors:  Mira Jung; Yonggang Ma; Rugmani Padmanabhan Iyer; Kristine Y DeLeon-Pennell; Andriy Yabluchanskiy; Michael R Garrett; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

9.  Quantification of MicroRNAs by Coupling Cyclic Enzymatic Amplification with Microfluidic Voltage-Assisted Liquid Desorption Electrospray Ionization Mass Spectrometry.

Authors:  Xiangtang Li; Pratik Rout; Rui Xu; Li Pan; Paul B Tchounwou; Yonggang Ma; Yi-Ming Liu
Journal:  Anal Chem       Date:  2018-11-06       Impact factor: 6.986

Review 10.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.